SHERRY DAVIS: Open Payments
NPI 1184820128 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 40 payments from 21 companies in 2025. Trend: 2023 $750 · 2024 $850 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $159 |
| Janssen Biotech, Inc. | 3 | $78 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $74 |
| Astellas Pharma US Inc | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $51 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Deciphera Pharmaceuticals Inc. | 1 | $37 |
| TerSera Therapeutics LLC | 1 | $36 |
Products named: VENCLEXTA, Xtandi, Enhertu, KEYTRUDA, EPKINLY, TALVEY, QINLOCK, Zoladex.
Industry payments across GA — which companies pay providers there.
